Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases

Lung Clinic Heckeshorn80 enrolled

Overview

Surgery has been available for the treatment of pulmonary metastases in metastatic colorectal cancer and promising overall survival was observed in retrospective studies with selected patients. This study investigated whether the preoperative FDG- PET/CT scan influences survival in this patient group. Furthermore, we tried to identify other prognostic factors associated with overall survival and progression-free survival.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Metastatic Colorectal Cancer

Interventions

PET-CTPROCEDURE

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients over 18 years with pulmonary metastases eligible for pulmonary metastasectomy Exclusion Criteria: * Second primary cancer within the last 2 years (exception basal cell carcinoma of the skin) * Pregnancy, * Drug addiction, * Renal dialysis

Locations (1)

Lung Clinic Heckeshorn at HELIOS Hospital Emil von Behring

Berlin, Germany

Outcomes

Primary Outcomes

Overall Survival

Time frame: 5 years

Secondary Outcomes

Number and sites of metastases detected by PET-CT

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.